Alterations in multipotent mesenchymal stromal cells from the bone marrow of acute myeloid leukemia patients at diagnosis and during treatment

References

• Blau O, Baldus CD, Hofmann WK, et al. Mesenchymal stromal cells of myelodysplastic syndrome and acute myeloid leukemia patients have distinct genetic abnormalities compared with leukemic blasts. Blood. 2011;118:5583–5592.
   PubMed Web of Science ®Google Scholar
• Dominici M, Le Blanc K, Mueller I, et al. Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy. 2006;8:315–317.
   PubMed Web of Science ®Google Scholar
• Lee CCI, Christensen JE, Yoder MC, et al. Clonal analysis and hierarchy of human bone marrow mesenchymal stem and progenitor cells. Exp Hematol. 2010;38:46–54.
   PubMed Web of Science ®Google Scholar
• Bigildeev AE, Zhironkina OA, Shipounova IN, et al. Clonal composition of human multipotent mesenchymal stromal cells. Exp Hematol. 2012;40:847–856.e4.
   PubMed Web of Science ®Google Scholar
• Chen Q, Yuan Y, Chen T. Morphology, differentiation and adhesion molecule expression changes of bone marrow mesenchymal stem cells from acute myeloid leukemia patients. Mol Med Rep. 2014;9:293–298.
   PubMed Web of Science ®Google Scholar
• Zhao ZG, Liang Y, Li K, et al. Phenotypic and functional comparison of mesenchymal stem cells derived from the bone marrow of normal adults and patients with hematologic malignant diseases. Stem Cells Dev. 2007;16:637–648.
   PubMed Web of Science ®Google Scholar
• Yin WJ, Yang PD, Huang YZ, et al. [Comparison of biological characteristics of bone marrow mesenchymal stem cells in acute myeloid leukemia with those from non-leukemia]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2009;17:395–399.
   PubMedGoogle Scholar
• Zhao ZG, Xu W, Sun L, et al. The characteristics and immunoregulatory functions of regulatory dendritic cells induced by mesenchymal stem cells derived from bone marrow of patient with chronic myeloid leukaemia. Eur J Cancer. 2012;48:1884–1895.
   PubMed Web of Science ®Google Scholar
• Zhu GR, Zhou XY, Lu H, et al. [Human bone marrow mesenchymal stem cells express multiple hematopoietic growth factors]. Zhongguo Shi Yan Xue Ye Xue Za Zhi. 2003;11:115–119.
   PubMedGoogle Scholar
• Zhao ZG, Sun L, Wang XF, et al. Immunomodulatory effects of mesenchymal stem cells derived from the bone marrow in acute leukemia patients. Chin J Oncol. 2011;33:105–109.
   Google Scholar
• Parovichnikova EN, Troitskaia VV, Kliasova GA, et al. [Treating patients with acute myeloid leukemias (AML) according to the protocol of the AML-01.10 Russian multicenter randomized trial: the coordinating center’s results]. Ter Arkh. 2014;86:14–23.
   PubMed Web of Science ®Google Scholar
• Lange C, Cakiroglu F, Spiess A, et al. Accelerated and safe expansion of human mesenchymal stromal cells in animal serum-free medium for transplantation and regenerative medicine. J Cell Physiol. 2007;8904:18–26.
   Google Scholar
• Kuzmina LA, Petinati NA, Parovichnikova EN, et al. Multipotent mesenchymal stromal cells for the prophylaxis of acute graft-versus-host disease-a phase II study. Stem Cells Int. 2012;2012:1.
   Google Scholar
• Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem. 1987;162:156–159.
   PubMed Web of Science ®Google Scholar
• Bigildeev AE, Zezina EA, Drize NJ. [The effects of interleukin-1 beta and gamma-quantum braking radiation on mesenchymal progenitor cells]. Mol Biol (Mosk). 2017;51:447–459.
   PubMed Web of Science ®Google Scholar
• Schmittgen TD, Livak KJ. Analyzing real-time PCR data by the comparative C(T) method. Nat Protoc. 2008;3:1101–1108.
   PubMed Web of Science ®Google Scholar
• Spitzer M, Wildenhain J, Rappsilber J, et al. BoxPlotR: a web tool for generation of box plots. Nat Methods. 2014;11:121–122.
   PubMed Web of Science ®Google Scholar
• Desbourdes L, Javary J, Charbonnier T, et al. Alteration analysis of bone marrow mesenchymal stromal cells from de novo acute myeloid leukemia patients at diagnosis. Stem Cells Dev. 2017;26:709–722.
   PubMed Web of Science ®Google Scholar
• Shipounova IN, Petinati NA, Bigildeev AE, et al. Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2016;58:1–10.
   Web of Science ®Google Scholar
• Lane SW, Scadden DT, Gilliland DG. The leukemic stem cell niche: current concepts and therapeutic opportunities. Blood. 2009;114:1150–1157.
   PubMed Web of Science ®Google Scholar
• Frisch BJ, Ashton JM, Xing L, et al. Functional inhibition of osteoblastic cells in an in vivo mouse model of myeloid leukemia. Blood. 2012;119:540–550.
   PubMed Web of Science ®Google Scholar
• Kim JA, Shim JS, Lee GY, et al. Microenvironmental remodeling as a parameter and prognostic factor of heterogeneous leukemogenesis in acute myelogenous leukemia. Cancer Res. 2015;75:2222–2231.
   PubMed Web of Science ®Google Scholar
• Woods A, Brull DJ, Humphries SE, et al. Genetics of inflammation and risk of coronary artery disease: the central role of interleukin-6. Eur Heart J. 2000;21:1574–1583.
   PubMed Web of Science ®Google Scholar
• Shellard J, Perreau J, Brûlet P. Role of leukemia inhibitory factor during mammalian development. Eur Cytokine Netw. 1996;7:699–712.
   PubMed Web of Science ®Google Scholar
• Trouillas M, Saucourt C, Guillotin B, et al. The LIF cytokine: towards adulthood. Eur Cytokine Netw. 2009;20:51–62.
   PubMed Web of Science ®Google Scholar
• Wetzler M, Talpaz M, Lowe DG, et al. Constitutive expression of leukemia inhibitory factor RNA by human bone marrow stromal cells and modulation by IL-1, TNF-alpha, and TGF-beta. Exp Hematol. 1991;19:347–351.
   PubMed Web of Science ®Google Scholar
• Lopes MR, Pereira JKN, de Melo Campos P, et al. De novo AML exhibits greater microenvironment dysregulation compared to AML with myelodysplasia-related changes. Sci Rep. 2017;7:40707.
   PubMed Web of Science ®Google Scholar
• Hacia JG, Lee CCI, Jimenez DF, et al. Age-related gene expression profiles of rhesus monkey bone marrow-derived mesenchymal stem cells. J Cell Biochem. 2008;103:1198–1210.
   PubMed Web of Science ®Google Scholar
• Jiang Y, Mishima H, Sakai S, et al. Gene expression analysis of major lineage-defining factors in human bone marrow cells: effect of aging, gender, and age-related disorders. J Orthop Res. 2008;26:910–917.
   PubMed Web of Science ®Google Scholar
• Kiersnowska-Rogowska B, Rogowski F, Petelski T, et al. [Cytokines in acute myeloid leukemia]. Pol Merkur Lekarski. 1998;4:259–261.
   PubMedGoogle Scholar
• Xiao R, Chen T, Zhou M, et al. [Abnormal expression of hematopoietic regulatory factors in newly diagnosed patients with acute myeloid leukemia]. Zhongguo Shi Yan Xue ye Xue za Zhi. 2010;18:1124–1127.
   PubMedGoogle Scholar
• Ng F, Boucher S, Koh S, et al. PDGF, TGF-beta, and FGF signaling is important for differentiation and growth of mesenchymal stem cells (MSCs): transcriptional profiling can identify markers and signaling pathways important in differentiation of MSCs into adipogenic, chondrogenic, and o. Blood. 2008;112:295–307.
   PubMed Web of Science ®Google Scholar
• Hu WL, Wu PP, Yin CC, et al. [Effects of leukemia inhibitory factor combined with basic fibroblast growth factor on self-maintenance and self-renewal of human umbilical cord mesenchymal stem cells in vitro]. Zhongguo Shi Yan Xue ye Xue za Zhi. 2016;24:184–190.
   PubMedGoogle Scholar
• Horacek JM, Kupsa T, Vasatova M, et al. Biochip array technology and evaluation of serum levels of multiple cytokines and adhesion molecules in patients with newly diagnosed acute myeloid leukemia. Exp Oncol. 2014;36:50–51.
   PubMedGoogle Scholar
• Zhang W, Qiao Z, Fan X, et al. [The role of intercellular adhesion molecule-1 in binding of acute myeloid leukemic blasts cells to human umbilical vein endothelial cells]. Zhonghua Nei ke za Zhi. 2003;42:413–416.
   PubMedGoogle Scholar
• Ren G, Zhao X, Zhang L, et al. Inflammatory cytokine-induced intercellular adhesion molecule-1 and vascular cell adhesion molecule-1 in mesenchymal stem cells are critical for immunosuppression. J Immunol. 2010;184:2321–2328.
   PubMed Web of Science ®Google Scholar
• Kampen KR, Ter Elst A, de Bont ES. Vascular endothelial growth factor signaling in acute myeloid leukemia. Cell Mol Life Sci. 2013;70:1307–1317.
   PubMed Web of Science ®Google Scholar
• Sanaat Z, Khalili R, Almasi S, et al. Does chemotherapy change expression of VEGF A&C and MVD in acute myeloid leukemia? Int J Hematol Oncol Stem Cell Res. 2014;8:24–29.
   PubMedGoogle Scholar
• Mikkola HK, Orkin SH. The journey of developing hematopoietic stem cells. Development. 2006;133:3733–3744.
   PubMed Web of Science ®Google Scholar
• Fouillard L, Francois S, Bouchet S, et al. Innovative cell therapy in the treatment of serious adverse events related to both chemo-radiotherapy protocol and acute myeloid leukemia syndrome: the infusion of mesenchymal stem cells post-treatment reduces hematopoietic toxicity and promotes hematopoietic reconstituion. Curr Pharm Biotechnol. 2014;14:842–848.
   Web of Science ®Google Scholar
• Voermans C, van Heese WPM, de Jong I, et al. Migratory behavior of leukemic cells from acute myeloid leukemia patients. Leukemia. 2002;16:650–657.
   PubMed Web of Science ®Google Scholar
• Juarez J, Bendall L. SDF-1 and CXCR4 in normal and malignant hematopoiesis. Histol Histopathol. 2004;19:299–309.
   PubMed Web of Science ®Google Scholar
• Liao J, Hu N, Zhou N, et al. Sox9 potentiates BMP2-induced chondrogenic differentiation and inhibits BMP2-induced osteogenic differentiation. PLoS One. 2014;9:e89025. Shi X-M, editor.
   PubMed Web of Science ®Google Scholar
• Loebel C, Czekanska EM, Bruderer M, et al. In vitro osteogenic potential of human mesenchymal stem cells is predicted by Runx2/Sox9 ratio. Tissue Eng Part A. 2015;21:115–123.
   PubMed Web of Science ®Google Scholar
• Shipounova IN, Petinati NA, Bigildeev AE, et al. Alterations of the bone marrow stromal microenvironment in adult patients with acute myeloid and lymphoblastic leukemias before and after allogeneic hematopoietic stem cell transplantation. Leuk Lymphoma. 2017;58:408–417.
   PubMed Web of Science ®Google Scholar
• Cheah CY, Burbury K, Apperley JF, et al. Patients with myeloid malignancies bearing PDGFRB fusion genes achieve durable long-term remissions with imatinib. Blood. 2014;123:3574–3577.
   PubMed Web of Science ®Google Scholar
• Kim HG, Jang JH, Koh EH. TRIP11-PDGFRB fusion in a patient with a therapy-related myeloid neoplasm with t(5;14)(q33;q32) after treatment for acute promyelocytic leukemia. Mol Cytogenet. 2014;7:103.
   PubMed Web of Science ®Google Scholar
• Vega F, Medeiros LJ, Bueso-Ramos CE, et al. Hematolymphoid neoplasms associated with rearrangements of PDGFRA, PDGFRB, and FGFR1. Am J Clin Pathol. 2015;144:377–392.
   PubMed Web of Science ®Google Scholar